Detalhe da pesquisa
1.
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer
; 148(7): 1685-1694, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33070307
2.
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting.
Breast Care (Basel)
; 19(1): 49-61, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384487